Das J, et al. The use of autologous haematopoietic stem cell transplantation as a first line disease modifying therapy in patients with 'aggressive' multiple sclerosis. ECTRIMS 2018, abstract 230.
Conclusies over behandeling van RSE met CIVAD’s beperkt
jun 2024 | Epilepsie